title: [Modern topical hemostatic agents - a breakthrough in vascular surgery].
abstract: OBJECTIVE
  The authors present the impact of the topical hemostatic agents (PerClot®, Fibrillar®, and Surgiflo®) in both primary arterial anastomoses, and anastomoses with synthetic prostheses.
  
  
  METHODS
  In 2012, in the Department of Vascular Surgery in Wroclaw, the topical hemostatic dressings were successfully applied to 106 patients (Fibrillar® - 65, PerClot® - 26, and Surgiflo® - 15) in case of difficulties to stop bleeding.
  
  
  RESULTS
  The topical hemostatic agents appear both to reduce blood loss and to shorten the operation time in 95% of cases.
  
  
  CONCLUSIONS
  The decrease both in blood loss and operation time can lead to the patient safety improvement.
authors.affiliation: Zakład Specjalności Zabiegowych, Katedra Pielęgniarstwa Klinicznego Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu, Wrocław, Polska.
authors.forename: Dariusz
authors.initials: D
authors.lastname: Janczak
authors.affiliation: Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
authors.forename: Artur
authors.initials: A
authors.lastname: Ruciński
authors.affiliation: Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
authors.forename: Zuzanna
authors.initials: Z
authors.lastname: Rucińska
authors.affiliation: Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
authors.forename: Dawid
authors.initials: D
authors.lastname: Janczak
authors.affiliation: Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
authors.forename: Karolina
authors.initials: K
authors.lastname: Dorobisz
authors.affiliation: Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
authors.forename: Mariusz
authors.initials: M
authors.lastname: Chabowski
mesh_terms: D000287:Administration, Topical; D001158:Arteries / Q000601:surgery; D001163:Arteriovenous Anastomosis; D001458:Bandages; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000379:methods; D024022:Fibrillar Collagens / Q000008:administration & dosage; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D014656:Vascular Surgical Procedures / Q000379:methods*
chemical_list: D024022:Fibrillar Collagens; D006490:Hemostatics